Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerias, Brazil.
Laboratório de Genética e Cardiologia Molecular do Instituto do Coração de São Paulo (INCOR), Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
Mol Biol Rep. 2020 Dec;47(12):9279-9288. doi: 10.1007/s11033-020-06014-0. Epub 2020 Nov 24.
Familial hypercholesterolemia (FH) is an autosomal dominant genetic disease characterized by high levels of low-density lipoprotein-cholesterol (LDLc), associated to premature cardiovascular disease. The detection of the variants related to FH is important to improve the early diagnosis in probands / index-cases (ICs) and their relatives. We included ICs with FH and their relatives, living in a small region of Minas Gerais state-Brazil, which were classified according to Dutch Lipid Clinic Network Criteria (DLCNC) and submitted to sequencing of genes related to FH (LDLR, APOB, PCSK9, LDLRAP1, LIPA, STAP1, APOE, ABCG5 e ABCG8). In a total of 143 subjects (32 ICs and 111 relatives), eight variants were identified in 91 individuals. From these variants, five were in LDLR [p.(Asp224Asn), p.(Ser854Gly), p.(Cys34Arg), p.(Asp601His), deletion of exon15 in LDLR)], one in APOB [p.(Met499Val)], one in PCSK9 [p.(Arg237Trp)] and one in APOE [p.(Pro28Leu)] genes. The variants were detected in 100% of those subjects classified as definitive, 87% as probable and 69% as possible FH cases based on DLCNC. The LDLc level was higher in individuals with corneal arch and xanthomas or xanthelasmas, as well as in pathogenic or probably pathogenic variants carriers. This study showed higher frequency of LDLR gene variants compared to other genes related to LDL metabolism in individuals with FH in Minas Gerais - Brazil and the presence of FH in relatives without previous diagnosis. Our data reinforce the importance of molecular and clinical evaluation of FH relatives in order to early diagnosis the FH, as well as cardiovascular diseases prevention.
家族性高胆固醇血症(FH)是一种常染色体显性遗传疾病,其特征为低密度脂蛋白胆固醇(LDLc)水平升高,与早发性心血管疾病相关。检测与 FH 相关的变异对于提高先证者/索引病例(ICs)及其亲属的早期诊断非常重要。我们纳入了居住在巴西米纳斯吉拉斯州一个小地区的 FH ICs 及其亲属,这些患者根据荷兰脂质诊所网络标准(DLCNC)进行分类,并接受与 FH 相关的基因测序(LDLR、APOB、PCSK9、LDLRAP1、LIPA、STAP1、APOE、ABCG5 和 ABCG8)。在总共 143 名受试者(32 名 ICs 和 111 名亲属)中,在 91 名个体中发现了 8 种变异。在这些变异中,有 5 种在 LDLR 中 [p.(Asp224Asn)、p.(Ser854Gly)、p.(Cys34Arg)、p.(Asp601His)、LDLR 外显子 15 缺失],1 种在 APOB 中 [p.(Met499Val)],1 种在 PCSK9 中 [p.(Arg237Trp)],1 种在 APOE 中 [p.(Pro28Leu)]。基于 DLCNC,在被分类为确定性、可能性和可能 FH 病例的患者中,100%、87%和 69%分别检测到这些变异。在有角膜弓、黄斑瘤或黄瘤的个体以及携带致病性或可能致病性变异的个体中,LDLc 水平更高。与其他与 LDL 代谢相关的基因相比,本研究在巴西米纳斯吉拉斯州的 FH 患者中发现 LDLR 基因突变的频率更高,并且在未经先前诊断的亲属中也存在 FH。我们的数据加强了对 FH 亲属进行分子和临床评估的重要性,以便早期诊断 FH 和预防心血管疾病。